Special Issue on
Advances in Hepatocellular Carcinoma Research
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Most cases of HCC are
secondary to either a viral hepatitis infection or cirrhosis. HCC may present
with yellow skin, loss of appetite, abdominal pain or felling tired. Prognosis and
treatment of HCC are mainly dependent on tumor size and staging. High-grade tumors
will have a poor prognosis, while low-grade tumors may go unnoticed for many
years. Getting vaccination and avoiding alcohol consumption are common methods
for prevention of HCC, while, liver transplantation and surgical resection are
major methods for treatment. As the high lethality of hepatocellular carcinoma, study on it is of great interest and necessity
to researchers.
In this special issue, we intend to invite front-line researchers and
authors to submit original research and review articles on exploring advances in hepatocellular carcinoma research.
Potential topics include, but are not limited to:
-
Signs and symptoms
-
Risk factors
-
Pathology of HCC
-
Diagnosis and prognosis
-
Prevention and treatment
-
Side effects and complication
-
Epidemiology
-
Research progress
Authors should read over the journal’s Authors’ Guidelines carefully before submission. Prospective authors should submit an
electronic copy of their complete manuscript through the journal’s Paper
Submission System.
Please kindly notice that the “Special Issue” under your manuscript
title is supposed to be specified and the research field “Special Issue - Advances in
Hepatocellular Carcinoma Research” should be chosen during your submission.
According to the following timetable:
Submission
Deadline
|
October 15th, 2014
|
Publication Date
|
December 2014
|
Guest Editor:
For
further questions or inquiries
Please
contact Editorial Assistant at
jct@scirp.org